nebivolol

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 42291-871
  • Package NDC 42291-871-30
  • Application number ANDA203821
  • SPL ID 48842030-a03d-fb38-e063-6294a90a9dd0
  • SPL set ID 1ce89dc5-018d-db40-e063-6294a90a9722
  • UNII JGS34J7L9I
  • RxCUI 387013
  • RxCUI 751612
  • RxCUI 751618
  • RxCUI 827073

What the source publishes

Labeler
AvKARE
Active ingredients
nebivolol hydrochloride
Form
TABLET
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:42291-871_48842030-a03d-fb38-e063-6294a90a9dd0
{
  "name": "nebivolol",
  "splId": "48842030-a03d-fb38-e063-6294a90a9dd0",
  "labels": [
    {
      "setId": "1ce89dc5-018d-db40-e063-6294a90a9722",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1ce89dc5-018d-db40-e063-6294a90a9722",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1ce89dc5-018d-db40-e063-6294a90a9722"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "AvKARE",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "30 TABLET in 1 BOTTLE (42291-871-30)",
      "package_ndc": "42291-871-30",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20240710"
    }
  ],
  "productId": "42291-871_48842030-a03d-fb38-e063-6294a90a9dd0",
  "useDomain": "unknown",
  "dosageForm": "TABLET",
  "productNdc": "42291-871",
  "deaSchedule": null,
  "genericName": "nebivolol hydrochloride",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "NEBIVOLOL HYDROCHLORIDE",
      "strength": "2.5 mg/1"
    }
  ],
  "applicationNumber": "ANDA203821",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20240710",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "upc": [
      "0342291872905",
      "0342291874909",
      "0342291873902"
    ],
    "unii": [
      "JGS34J7L9I"
    ],
    "rxcui": [
      "387013",
      "751612",
      "751618",
      "827073"
    ],
    "spl_set_id": [
      "1ce89dc5-018d-db40-e063-6294a90a9722"
    ],
    "manufacturer_name": [
      "AvKARE"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:42291-871_48842030-a03d-fb38-e063-6294a90a9dd0"